Zhilei Wang

机构：Chinese PLA General Hospital, First Affiliated Hospital of Henan University, Chengdu University of Traditional Chinese Medicine · ORCID：0000-0001-5518-954X

发表论文 57 篇 · 总被引 1670 次 · h-index 22

代表论文

Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout (2022 · Frontiers in Cellular and Infection Microbiology · 被引 146)
Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7‐NLRP3 interaction (2021 · EMBO Reports · 被引 111)
NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation (2022 · DOAJ (DOAJ: Directory of Open Access Journals) · 被引 22)
The role of NLRP3 inflammasome in psychotropic drug-induced hepatotoxicity (2022 · Cell Death Discovery · 被引 20)
Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases (2024 · The American Journal of Chinese Medicine · 被引 18)
Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy (2022 · International Journal of Nanomedicine · 被引 17)